Results 151 to 160 of about 18,161,920 (183)

Non-covalent interactions between sertraline stereoisomers and 2-hydroxypropyl-β-cyclodextrin: a quantum chemistry analysis. [PDF]

RSC Adv, 2020
Bautista-Renedo JM, Cuevas-Yañez E, Reyes-Pérez H, Vargas R, Garza J, González-Rivas N.   +5 more
europepmc   +1 more source

Acute and Subacute Toxicity Assessment of Andrographolide-2-hydroxypropyl-β-cyclodextrin Complex via Oral and Inhalation Route of Administration in Sprague-Dawley Rats. [PDF]

ScientificWorldJournal, 2022
Chandrama Singh S, Choudhary M, Mourya A, Khatri DK, Singh PK, Madan J, Singh H.   +6 more
europepmc   +1 more source

Probing inclusion complexes of 2-hydroxypropyl-β-cyclodextrin with mono-amino mono-carboxylic acids: physicochemical specification, characterization and molecular modeling. [PDF]

Heliyon, 2020
Esmaeilpour D, Hussein AA, Almalki FA, Shityakov S, Bordbar AK.   +4 more
europepmc   +1 more source

2-Hydroxypropyl-β-cyclodextrin Ototoxicity in Adult Rats: Rapid Onset and Massive Destruction of Both Inner and Outer Hair Cells Above a Critical Dose. [PDF]

Neurotox Res, 2020
Liu X, Ding D, Chen GD, Li L, Jiang H, Salvi R.   +5 more
europepmc   +1 more source

2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis. [PDF]

J Control Release, 2019
Pons-Faudoa FP, Sizovs A, Di Trani N, Paez-Mayorga J, Bruno G, Rhudy J, Manohar M, Gwenden K, Martini C, Chua CYX, Varchi G, Marzinke MA, Grattoni A.   +12 more
europepmc   +1 more source

2-Hydroxypropyl-β-Cyclodextrin Aggregates: Identification and Development of Analytical Techniques. [PDF]

Materials (Basel), 2018
Sá Couto AR, Ryzhakov A, Loftsson T.
europepmc   +1 more source

Cavity Closure of 2-Hydroxypropyl-β-Cyclodextrin: Replica Exchange Molecular Dynamics Simulations. [PDF]

Polymers (Basel), 2019
Kerdpol K, Kicuntod J, Wolschann P, Mori S, Rungnim C, Kunaseth M, Okumura H, Kungwan N, Rungrotmongkol T.   +8 more
europepmc   +1 more source

2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease. [PDF]

Biochim Biophys Acta Mol Cell Biol Lipids, 2019
Davidson J, Molitor E, Moores S, Gale SE, Subramanian K, Jiang X, Sidhu R, Kell P, Zhang J, Fujiwara H, Davidson C, Helquist P, Melancon BJ, Grigalunas M, Liu G, Salahi F, Wiest O, Xu X, Porter FD, Pipalia NH, Cruz DL, Holson EB, Schaffer JE, Walkley SU, Maxfield FR, Ory DS.   +25 more
europepmc   +1 more source

Designing a Formulation of the Nootropic Drug Aniracetam Using 2-Hydroxypropyl-β-Cyclodextrin Suitable for Parenteral Administration. [PDF]

Pharmaceutics, 2018
Goldsmith SD, McDowell A.
europepmc   +1 more source